Open Nav

Sam Alworth, MBA, MS

Chief Executive Officer

AcuraStem Incorporated

Sam Alworth is the CEO of AcuraStem Inc., a biotechnology startup working on cures and improved diagnoses for Amyotrophic Lateral Sclerosis, Frontotemporal Dementia and Alzheimer's Disease. AcuraStem utilizes advanced stem cell technology and machine learning to study diseases of the central nervous system using living neurons from current patients – a virtual nerve biopsy. He strongly believes that this approach will soon deliver new insights into the clinic, and new therapies for challenging CNS disorders.

Sam has over 15 years’ experience in entrepreneurship, product management, business development and R&D in the life sciences, and has raised over $19M from investors and nondilutive government R&D funding. He has the bioinformatics and machine learning expertise required to drive the new experiments using human cell models, and a proven ability to manage large international, multidisciplinary scientific projects. Sam has several U.S. patents and scientific journal publications.

This speaker's sessions: